UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 6
June-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2106264


Registration ID:
310592

Page Number

b865-b877

Share This Article


Jetir RMS

Title

Development and validation of stability indicating method for simultaneous estimation of montelukast sodium and bilastine from its pharmaceutical dosage form

Abstract

A simple, precise and accurate newly developed and validated method for Stability Indicating Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method for Simultaneous Estimation of Montelukast Sodium (MON) and Bilastine (BIL) from its pharmaceutical dosage form. A reverse phase high performance liquid chromatographic method was developed for the Simultaneous Estimation of Montelukast Sodium (MON) and Bilastine (BIL) in Pharmaceutical Dosage Form. The separation was achieved by Hypersil ODS C18 5µ column (250 x 4.6 mm) Column and ACN: Water = 70:30 v/v as mobile phase, at a flow rate of 0.8 ml/min. Detection was carried out at 215 nm. Retention time of Montelukast Sodium and Bilastine was found to be 7.374 min. and 4.819 min. respectively. The method has been validated for linearity, accuracy and precision. Linearity observed for Montelukast Sodium 10-50 μg/ml and for Bilastine 20-100 μg/ml. Developed method was found to be accurate, precise and rapid for Simultaneous estimation of Montelukast Sodium (MON) and Bilastine (BIL) in pharmaceutical dosage form.Forced degradation studies were performed under different conditions like hydrolysis, oxidation and Thermal degradation. Considerable Degradation was found in Acid degradation.The method was validated according to ICH guidelines Q2 (R1).

Key Words

Cite This Article

"Development and validation of stability indicating method for simultaneous estimation of montelukast sodium and bilastine from its pharmaceutical dosage form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 6, page no.b865-b877, June-2021, Available :http://www.jetir.org/papers/JETIR2106264.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Development and validation of stability indicating method for simultaneous estimation of montelukast sodium and bilastine from its pharmaceutical dosage form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 6, page no. ppb865-b877, June-2021, Available at : http://www.jetir.org/papers/JETIR2106264.pdf

Publication Details

Published Paper ID: JETIR2106264
Registration ID: 310592
Published In: Volume 8 | Issue 6 | Year June-2021
DOI (Digital Object Identifier):
Page No: b865-b877
Country: Ahmedabad, Gujarat, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000699

Print This Page

Current Call For Paper

Jetir RMS